Amplia Therapeutics Limited (ATX.AX) - Stock Prices, Stock Peers & Analysis

Home
ATX.AX

Company Name	Amplia Therapeutics Limited
Symbol	ATX.AX
Currency	AUD
Price	0.25
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	96,988,250
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.049 - 0.27
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Christopher J. Burns B.Sc., BSc(Hons), Ph.D.
Website	https://www.ampliatx.com

An error occurred while fetching data.

About Amplia Therapeutics Limited

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has